Literature DB >> 21102262

Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.

Shinya Neri1, Yutaka Takahashi, Takuya Terashi, Hiroshi Hamakawa, Keisuke Tomii, Nobuyuki Katakami, Masaki Kokubo.   

Abstract

INTRODUCTION: Stereotactic body radiotherapy (SBRT) has been proposed as an alternative to surgery for the treatment of lung cancer. The treatment of local recurrence that occurs after SBRT has not been reported. We present surgical outcomes for local recurrence following SBRT for primary and metastatic lung cancers.
METHODS: Seven of the patients who received SBRT between 2002 and 2008 underwent salvage surgery for local recurrence. These seven patients (two with stage I non-small cell lung cancer and five with metastatic tumors) were operable, although they refused surgery and chose SBRT for the first treatment as a less invasive procedure.
RESULTS: Six of the seven patients underwent lobectomy, and the other patient underwent segmentectomy. None of the seven patients had direct pleural adhesion resulting from SBRT, although, in general, radiation fibrosis occurs after radiotherapy and induces pleural adhesion that makes surgery difficult.
CONCLUSIONS: Our study suggests that SBRT may not be the cause of difficulties encountered during the surgical process, and surgery is a good alternative treatment for local recurrence after SBRT. During follow-up after SBRT, the appearance of tumor regrowth on lung images resembled that of inflammatory changes such as radiation pneumonitis. We suggest that close follow-ups should be mandatory after SBRT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102262     DOI: 10.1097/JTO.0b013e3181f8a785

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  23 in total

1.  Salvage video-assisted thoracoscopic lobectomy for isolated local relapse after stereotactic body radiotherapy for early stage non-small cell lung cancer: technical aspects and perioperative management.

Authors:  Masatsugu Hamaji; Toyofumi-Fengshi Chen-Yoshikawa; Yukinori Matsuo; Hideki Motoyama; Kyoko Hijiya; Toshi Menju; Akihiro Aoyama; Toshihiko Sato; Makoto Sonobe; Hiroshi Date
Journal:  J Vis Surg       Date:  2017-06-22

2.  Lobectomy: no port at all?

Authors:  Yanping Ren; Yuxin Jiao; Xiangpeng Zheng
Journal:  Ann Transl Med       Date:  2017-05

Review 3.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 4.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

5.  Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies.

Authors:  Suresh Senan; David A Palma; Frank J Lagerwaard
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

Review 6.  Current Topics on Salvage Thoracic Surgery in Patients with Primary Lung Cancer.

Authors:  Hidetaka Uramoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-03-04       Impact factor: 1.520

Review 7.  Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?

Authors:  Esengül Koçak Uzel; Ufuk Abacıoğlu
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

8.  Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.

Authors:  Jeremy M Kilburn; Jeffrey G Kuremsky; A William Blackstock; Michael T Munley; William T Kearns; William H Hinson; James F Lovato; Antonius A Miller; William J Petty; James J Urbanic
Journal:  Radiother Oncol       Date:  2014-01-17       Impact factor: 6.280

9.  Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.

Authors:  Yasushi Hamamoto; Masaaki Kataoka; Motohiro Yamashita; Naoyuki Nogami; Yoshifumi Sugawara; Toshiyuki Kozuki; Shigeki Sawada; Hiroshi Suehisa; Syuichi Shinohara; Naomi Nakajima; Tetsu Shinkai
Journal:  Jpn J Radiol       Date:  2012-07-20       Impact factor: 2.374

10.  Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.

Authors:  Jeremy M Kilburn; Scott C Lester; John T Lucas; Michael H Soike; A William Blackstock; William T Kearns; William H Hinson; Antonius A Miller; William J Petty; Michael T Munley; James J Urbanic
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.